The proteins identified as significant for MS by confidence intervals within each group in cohort 1, and for CIS within group A in cohort 2 were among the proteins selected by Martens’ uncertainly test, with only one exception, HP, which was significant by univariate validation but not by the multivariate validation. The gene discussed is HP; the disease is in situ carcinoma.